Clinical Trial: EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Multizenterstudie Der European Assessment Group for Lysis in the Eye (EAGLE) Zur Behandlung Des Zentralarterienverschlusses (ZAV): Lysetherapie Versus Konservative Therapie
Brief Summary: The aim of the EAGLE Study is to compare the efficacy of conservative medical treatment and local intraarterial fibrinolysis in patients with central retinal artery occlusion and to evaluate benefit and risk for the patient of both therapies.
Detailed Summary:
Sponsor: University Hospital Freiburg
Current Primary Outcome: Visual acuity 1 month after therapy in comparison with visual acuity before therapy measured according to ETDRS Scale. [ Time Frame: 1 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Improvement of visual field [ Time Frame: 1 month ]
- Effect on retinal circulation [ Time Frame: 1 month ]
- Tolerance of therapies and registration of number, form and severity of complications [ Time Frame: 1 month ]
- Evaluation of prognostic factors
Original Secondary Outcome: Same as current
Information By: University Hospital Freiburg
Dates:
Date Received: March 11, 2008
Date Started: September 2002
Date Completion:
Last Updated: March 17, 2008
Last Verified: March 2008
